| Primary |
| Factor Ix Deficiency |
69.1% |
| Haemophilia |
10.5% |
| Prophylaxis |
6.4% |
| Haemorrhage |
2.5% |
| Pain |
2.1% |
| Factor Viii Deficiency |
1.1% |
| Asthma |
1.0% |
| Haemophilia B With Anti Factor Ix |
0.8% |
| Haemorrhage Prophylaxis |
0.8% |
| Epilepsy |
0.7% |
| Infection |
0.7% |
| Rectal Haemorrhage |
0.7% |
| Constipation |
0.5% |
| Factor Ix Inhibition |
0.5% |
| Haemarthrosis |
0.5% |
| Hypersensitivity |
0.5% |
| Orchidopexy |
0.5% |
| Surgery |
0.5% |
| Thermal Burn |
0.5% |
| Arthralgia |
0.3% |
|
| Factor Ix Inhibition |
19.2% |
| Off Label Use |
15.6% |
| Haemorrhage |
12.9% |
| Joint Injury |
9.6% |
| Urticaria |
5.7% |
| Haemarthrosis |
4.5% |
| Drug Ineffective |
4.2% |
| Pyrexia |
4.2% |
| Hypersensitivity |
3.6% |
| Death |
2.4% |
| Pharmaceutical Product Complaint |
2.4% |
| Vomiting |
2.4% |
| Wrong Drug Administered |
2.1% |
| Epistaxis |
1.8% |
| Muscle Haemorrhage |
1.8% |
| Pruritus |
1.8% |
| Anaphylactic Reaction |
1.5% |
| Angina Pectoris |
1.5% |
| Arthropathy |
1.5% |
| Haematoma |
1.5% |
|
| Secondary |
| Factor Ix Deficiency |
52.4% |
| Epilepsy |
11.5% |
| Prophylaxis |
8.1% |
| Haemophilia |
6.1% |
| Pain |
5.1% |
| Haemostasis |
3.6% |
| Haemorrhage |
2.7% |
| Haemarthrosis |
1.7% |
| Factor Ix Inhibition |
1.4% |
| Central Venous Catheterisation |
1.0% |
| Constipation |
1.0% |
| Orchidopexy |
1.0% |
| Dental Care |
0.7% |
| Epistaxis |
0.7% |
| Hiv Infection |
0.7% |
| Hypersensitivity |
0.7% |
| Ear Infection |
0.5% |
| Rectal Haemorrhage |
0.5% |
| Dental Discomfort |
0.3% |
| Haematoma |
0.3% |
|
| Factor Ix Inhibition |
21.5% |
| Off Label Use |
11.9% |
| Pharmaceutical Product Complaint |
9.2% |
| Device Related Infection |
6.1% |
| Vision Blurred |
5.4% |
| Urticaria |
5.0% |
| Skull Fracture |
4.6% |
| Haemorrhage |
3.8% |
| Serum Sickness |
3.8% |
| Coagulation Factor Ix Level Decreased |
3.4% |
| Tremor |
3.4% |
| Drug Ineffective |
3.1% |
| Hypersensitivity |
3.1% |
| Pyrexia |
3.1% |
| Superior Vena Caval Occlusion |
2.3% |
| Vomiting |
2.3% |
| Weight Decreased |
2.3% |
| Epistaxis |
1.9% |
| Haemarthrosis |
1.9% |
| Herpes Zoster |
1.9% |
|
| Concomitant |
| Rheumatoid Arthritis |
13.5% |
| Drug Use For Unknown Indication |
10.8% |
| Cardiac Disorder |
9.5% |
| Bronchitis |
8.8% |
| Depression |
6.8% |
| Diabetes Mellitus |
6.8% |
| Emphysema |
6.8% |
| Labyrinthitis |
6.8% |
| Pain |
6.8% |
| Swelling |
6.8% |
| Thyroid Disorder |
6.8% |
| Hepatitis C |
4.7% |
| Dyspnoea |
1.4% |
| Asthma |
0.7% |
| Bronchitis Chronic |
0.7% |
| Chronic Hepatitis C |
0.7% |
| Factor Ix Deficiency |
0.7% |
| Lung Disorder |
0.7% |
| Nervousness |
0.7% |
|
| Fracture |
58.8% |
| Hepatitis C |
5.9% |
| Hypersensitivity |
5.9% |
| Nephrotic Syndrome |
5.9% |
| Neutrophil Count Decreased |
5.9% |
| Sciatic Nerve Injury |
5.9% |
| Thyroid Adenoma |
5.9% |
| Thyroid Cancer |
5.9% |
|
